3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Cardiotoxicity
14
Breast Neoplasms
10
Neoplasms
4
Heart Failure
4
Heart Diseases
2
Cardiovascular Diseases
2
Ventricular Dysfunction, Left
1
Ventricular Dysfunction
1
Thoracic Neoplasms
1
Radiation Injuries
1
Prostatic Neoplasms
1
Peritoneal Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Metabolic Syndrome
1
Memory Disorders
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Dyspnea
1
Dyslipidemias
1
Cognitive Dysfunction
1
Central Nervous System Neoplasms
1
Cardiomyopathies
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms, Male
1
Bone Neoplasms
1
Atherosclerosis
1
Interventions
Nebivolol
1
Methods
1
Exercise Therapy
1
Exercise
1
Electrocardiography
1
Echocardiography
1
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Ventricular Dysfunction, Left
×
Echocardiography
×
Clear all
NCT05939089
2023-07-11
CASPER
Istanbul University
Completed
54 enrolled